Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuang Peng

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Annals of Medicine|February 15, 2024
Advances in targeted therapy of cholangiocarcinomaYuhang Li, Jianfeng Yu, Yujing Zhang, et al.
Molecular Medicine Reports|March 18, 2022
Insights into the role of STAT3 in intrahepatic cholangiocarcinoma (Review)Ranzhiqiang Yang, Yinghui Song, Kashif Shakoor, et al.
Scientific Reports|April 22, 2015
Cell voltage versus electrode potential range in aqueous supercapacitorsZengxin Dai, Chuang Peng, Jung Hoon Chae, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|September 22, 2022
T-tube bridging fistula jejunal anastomosis for treatment of pancreatic lumbar dorsal fistula after necrotizing pancreatitisSu-Lai Liu, Guo-Guang Li, Wei Cheng, et al.
Discover Oncology|April 16, 2025
The optimal number of examined lymph nodes for cancer specific death of intrahepatic cholangiocarcinoma: a population-based studyChaojia Ou, Yufan Zhou, You Tang, et al.
RSC Advances|May 6, 2022
Nitrogen doped microporous carbon nanospheres derived from chitin nanogels as attractive materials for supercapacitorsSi Zheng, Yin Cui, Jianwei Zhang, et al.
Gastroenterology Research and Practice|June 7, 2021
Small Incision Combined with Nephroscope Operation in the Treatment of Infectious Pancreatic Necrosis: A Single-Center Experience of 37 PatientsYinghui Song, Guoguang Li, Hongwei Zhu, et al.
Experimental and Molecular Pathology|April 20, 2021
Long non-coding RNA muskelin 1 antisense RNA (MKLN1-AS) is a potential diagnostic and prognostic biomarker and therapeutic target for hepatocellular carcinomaChao Guo, Shuhuang Zhou, Weimin Yi, et al.
Translational Oncology|February 22, 2024
Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinomaXu Chen, Bo Sun, Yu Chen, et al.
International Journal of Oncology|May 23, 2019
Leptin stimulates the epithelial‑mesenchymal transition and pro‑angiogenic capability of cholangiocarcinoma cells through the miR‑122/PKM2 axisChuang Peng, Zengpeng Sun, Ou Li, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Annals of Medicine|February 15, 2024
Advances in targeted therapy of cholangiocarcinomaYuhang Li, Jianfeng Yu, Yujing Zhang, et al.
Molecular Medicine Reports|March 18, 2022
Insights into the role of STAT3 in intrahepatic cholangiocarcinoma (Review)Ranzhiqiang Yang, Yinghui Song, Kashif Shakoor, et al.
Scientific Reports|April 22, 2015
Cell voltage versus electrode potential range in aqueous supercapacitorsZengxin Dai, Chuang Peng, Jung Hoon Chae, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|September 22, 2022
T-tube bridging fistula jejunal anastomosis for treatment of pancreatic lumbar dorsal fistula after necrotizing pancreatitisSu-Lai Liu, Guo-Guang Li, Wei Cheng, et al.
Discover Oncology|April 16, 2025
The optimal number of examined lymph nodes for cancer specific death of intrahepatic cholangiocarcinoma: a population-based studyChaojia Ou, Yufan Zhou, You Tang, et al.
RSC Advances|May 6, 2022
Nitrogen doped microporous carbon nanospheres derived from chitin nanogels as attractive materials for supercapacitorsSi Zheng, Yin Cui, Jianwei Zhang, et al.
Gastroenterology Research and Practice|June 7, 2021
Small Incision Combined with Nephroscope Operation in the Treatment of Infectious Pancreatic Necrosis: A Single-Center Experience of 37 PatientsYinghui Song, Guoguang Li, Hongwei Zhu, et al.
Experimental and Molecular Pathology|April 20, 2021
Long non-coding RNA muskelin 1 antisense RNA (MKLN1-AS) is a potential diagnostic and prognostic biomarker and therapeutic target for hepatocellular carcinomaChao Guo, Shuhuang Zhou, Weimin Yi, et al.
Translational Oncology|February 22, 2024
Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinomaXu Chen, Bo Sun, Yu Chen, et al.
International Journal of Oncology|May 23, 2019
Leptin stimulates the epithelial‑mesenchymal transition and pro‑angiogenic capability of cholangiocarcinoma cells through the miR‑122/PKM2 axisChuang Peng, Zengpeng Sun, Ou Li, et al.
Pageof 11